0001209191-21-026667.txt : 20210414
0001209191-21-026667.hdr.sgml : 20210414
20210414164446
ACCESSION NUMBER: 0001209191-21-026667
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210413
FILED AS OF DATE: 20210414
DATE AS OF CHANGE: 20210414
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Novo Holdings A/S
CENTRAL INDEX KEY: 0001388325
STATE OF INCORPORATION: G7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40315
FILM NUMBER: 21826153
BUSINESS ADDRESS:
STREET 1: TUBORG HAVNEVEJ 19
CITY: HELLERUP
STATE: G7
ZIP: 2900
BUSINESS PHONE: 45 8824 8824
MAIL ADDRESS:
STREET 1: TUBORG HAVNEVEJ 19
CITY: HELLERUP
STATE: G7
ZIP: 2900
FORMER NAME:
FORMER CONFORMED NAME: Novo A/S
DATE OF NAME CHANGE: 20070130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Reneo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001637715
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472309515
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: P.O. BOX 675614
CITY: RANCHO SANTA FE
STATE: CA
ZIP: 92067
BUSINESS PHONE: 619-733-3852
MAIL ADDRESS:
STREET 1: P.O. BOX 675614
CITY: RANCHO SANTA FE
STATE: CA
ZIP: 92067
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-13
0
0001637715
Reneo Pharmaceuticals, Inc.
RPHM
0001388325
Novo Holdings A/S
TUBORG HAVNEVEJ 19
HELLERUP
G7
2900
DENMARK
0
0
1
0
COMMON STOCK
2021-04-13
4
C
0
2763711
A
2763711
D
COMMON STOCK
2021-04-13
4
P
0
666666
15.00
A
3430377
D
SERIES B CONVERTIBLE PREFERRED STOCK
2021-04-13
4
C
0
12367054
D
COMMON STOCK
2763711
0
D
Each share of Series B Convertible Preferred Stock converted into common stock at a ratio of 1:4.47848 into the number of shares of common stock as shown in Column 7 upon the closing of the Issuer's initial public offering without payment of additional consideration. These shares have no expiration date.
Represents a purchase from the underwriters in the Issuer's initial public offering.
Novo Holdings A/S is a Danish limited liability company. The board of directors of Novo Holdings A/S (the "Novo Board") has shared investment and voting control over the securities of the Issuer held by Novo Holdings A/S (the "Shares") and may exercise such control only with the support of a majority of the Novo Board. As such, no individual member of the Novo Board is deemed to hold any beneficial ownership or reportable pecuniary interest in the Shares.
/s/ Peter Haahr, Chief Financial Officer of Novo Holdings A/S
2021-04-14